PEAK6 Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,800
Closed -$226K 5840
2020
Q4
$226K Sell
1,800
-1,000
-36% -$112K ﹤0.01% 3688
2020
Q3
$284K Buy
2,800
+1,100
+65% +$112K ﹤0.01% 3254
2020
Q2
$165K Hold
1,700
﹤0.01% 3536
2020
Q1
$141K Buy
+1,700
New +$166K ﹤0.01% 3103
2019
Q3
Sell
-100
Closed -$10K 4513
2019
Q2
$10K Sell
100
-6,900
-99% -$659K ﹤0.01% 3491
2019
Q1
$772K Buy
+7,000
New +$732K ﹤0.01% 2057

Other funds holding PRAH

PEAK6 Investments's PRAH Position: Q2 2021 in Review

PEAK6 Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 11,008 shares — an estimated $1.69M sold.

PEAK6 Investments first reported a position in PRAH in Q3 2018 and held it in 9 quarters. The position peaked at $6.08M in Q2 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • PEAK6 Investments reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • PEAK6 Investments sold 11,008 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $1.69M.
  • PEAK6 Investments first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 9 quarters.
  • PEAK6 Investments's PRA Health Sciences, Inc. position peaked at $6.08M in Q2 2019.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on PEAK6 Investments's 13F filing for Q2 2021, filed 13 Aug 2021.